Cancer Biomarkers Market Players:
- INOVIQ
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Becton, Dickinson and Company
- Merck KGaA
- CENTOGENE GmbH
- PerkinElmer Inc.
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd
- Bristol Myers Squibb Company (BMS)
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cancer biomarkers is estimated at USD 38.74 Billion.
The global cancer biomarkers market size crossed USD 35.02 Billion in 2025 and is likely to register a CAGR of over 11.8%, exceeding USD 106.84 Billion revenue by 2035.
North America cancer biomarkers market will hold over 42.6% share by 2035, driven by rising population, growing research, and increasing affordability of treatments.
Key players in the market include INOVIQ, Bio-Rad Laboratories, Inc., Abbott Laboratories, Becton, Dickinson and Company, Merck KGaA, CENTOGENE GmbH, PerkinElmer Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Bristol Myers Squibb Company (BMS).
